Loading HuntDB...

CVE-2024-0387

MEDIUM
Published 2024-02-26T13:26:56.551Z
Actions:

Expert Analysis

Professional remediation guidance

Get tailored security recommendations from our analyst team for CVE-2024-0387. We'll provide specific mitigation strategies based on your environment and risk profile.

CVSS Score

V3.1
6.5
/10
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:L
Base Score Metrics
Exploitability: N/A Impact: N/A

EPSS Score

v2025.03.14
0.003
probability
of exploitation in the wild

There is a 0.3% chance that this vulnerability will be exploited in the wild within the next 30 days.

Updated: 2025-06-25
Exploit Probability
Percentile: 0.490
Higher than 49.0% of all CVEs

Attack Vector Metrics

Attack Vector
ADJACENT_NETWORK
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
CHANGED

Impact Metrics

Confidentiality
LOW
Integrity
LOW
Availability
LOW

Description

The EDS-4000/G4000 Series prior to version 3.2 includes IP forwarding capabilities that users cannot deactivate. An attacker may be able to send requests to the product and have it forwarded to the target. An attacker can bypass access controls or hide the source of malicious requests.

Understanding This Vulnerability

This Common Vulnerabilities and Exposures (CVE) entry provides detailed information about a security vulnerability that has been publicly disclosed. CVEs are standardized identifiers assigned by MITRE Corporation to track and catalog security vulnerabilities across software and hardware products.

The severity rating (MEDIUM) indicates the potential impact of this vulnerability based on the CVSS (Common Vulnerability Scoring System) framework. Higher severity ratings typically indicate vulnerabilities that could lead to more significant security breaches if exploited. Security teams should prioritize remediation efforts based on severity, exploit availability, and the EPSS (Exploit Prediction Scoring System) score, which predicts the likelihood of exploitation in the wild.

If this vulnerability affects products or systems in your infrastructure, we recommend reviewing the affected products section, checking for available patches or updates from vendors, and implementing recommended workarounds or solutions until a permanent fix is available. Organizations should also monitor security advisories and threat intelligence feeds for updates about active exploitation of this vulnerability.

Available Exploits

No exploits available for this CVE.

Related News

No news articles found for this CVE.

Affected Products

References

Solutions

Moxa has developed appropriate solutions to address the vulnerabilities. The solutions for affected products are shown below.

* EDS-4000/G4000 Series: Please contact Moxa Technical Support for the security patch (v3.2.26).

EU Vulnerability Database

Monitored by ENISA for EU cybersecurity

EU Coordination

Not EU Coordinated

Exploitation Status

No Known Exploitation

ENISA Analysis

Malicious code in bioql (PyPI)

Affected Products (ENISA)

moxa
eds-g4012 series

ENISA Scoring

CVSS Score (3.1)

6.5
/10
CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:L

EPSS Score

0.270
probability

Data provided by ENISA EU Vulnerability Database. Last updated: October 3, 2025

GitHub Security Advisories

Community-driven vulnerability intelligence from GitHub

⚠ Unreviewed MODERATE

GHSA-8q86-4x73-99v8

Advisory Details

The EDS-4000/G4000 Series prior to version 3.2 includes IP forwarding capabilities that users cannot deactivate. An attacker may be able to send requests to the product and have it forwarded to the target. An attacker can bypass access controls or hide the source of malicious requests.

CVSS Scoring

CVSS Score

5.0

CVSS Vector

CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:L

Advisory provided by GitHub Security Advisory Database. Published: February 26, 2024, Modified: February 26, 2025

References

Published: 2024-02-26T13:26:56.551Z
Last Modified: 2024-10-28T06:15:50.712Z
Copied to clipboard!